arrow
A

Ariane Boumendil

department of biostatistics
H指数:44
被引数:6,903

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical outcomes of newly diagnosed myeloma patients with SLIM criteria : a subgroup analysis of the CASSIOPEIA study

新诊断多发性骨髓瘤患者SLIM标准下的临床结局:CASSIOPEIA研究中的亚组分析

Leukemia
IF13.4
2026-08-130
PRE
Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis.

异基因造血干细胞移植在免疫检查点抑制剂时代霍奇金淋巴瘤中的疗效:CIBMTR与EBMT联合分析。

Blood
IF23.1
2025-07-090
PRE
Prognosis of Nonagenarian ICU Patients A Bayesian analysis of prospective European studies

非agenarian ICU患者的预后:一项基于前瞻性欧洲研究的贝叶斯分析

2025-06-230
OAAI
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)

异基因造血干细胞移植治疗老年急性淋巴细胞白血病患者:一项来自Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)的登记研究

2025-05-060
PRE
Teclistamab in relapsed refractory multiple myeloma: a multi-institutional real-world study from the French early access program

Teclesitamab在复发难治性多发性骨髓瘤中的应用:一项来自法国早期准入项目的多中心真实世界研究

2024-11-211
OA
The association of premorbid conditions with 6-month mortality in acutely admitted ICU patients over 80 years

80岁以上急性ICU患者病前状况与6个月死亡率的关系

2024-03-304
OAAI
Post-Transplantation Cyclophosphamide-Based Graft-versusHost Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

霍奇金淋巴瘤患者的HLA匹配和半相合供体移植中基于环磷酰胺的移植后疾病预防: 欧洲血液和骨髓移植学会淋巴瘤工作组的比较研究

2024-02-018
PRE
In reply: Sex-specific outcomes in COVID-19: missing pieces of the puzzle

回复: 新型冠状病毒肺炎中特定性别的结果: 拼图的缺失

2023-05-100
OAAI
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis
LEUKEMIA
IF13.4
2023-05-088
OAAI
The Clinical Frailty Scale for mortality prediction of old acutely admitted intensive care patients: a meta-analysis of individual patient-level data

用于预测老年急性重症监护患者死亡率的临床虚弱量表: 个体患者水平数据的荟萃分析

2023-05-0328
OAAI
Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas

使用移植后环磷酰胺治疗淋巴瘤的单倍体相合与匹配的无关供体移植

2023-03-0112
OAAI
Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters
LEUKEMIA
IF13.4
2022-12-226
PRE
A retrospective cohort study comparing differences in 30-day mortality among critically ill patients aged ≥ 70 years treated in European tax-based healthcare systems (THS) versus social health insurance systems

一项回顾性队列研究,比较了欧洲基于税收的医疗保健系统 (THS) 与社会健康保险系统治疗的 ≥ 70岁重症患者30天死亡率的差异

2022-10-192
OAAI
Sex-specific treatment characteristics and 30-day mortality outcomes of critically ill COVID-19 patients over 70 years of age-results from the prospective COVIP study

70岁以上重症新型冠状病毒肺炎患者的性别特异性治疗特征和30天死亡率结果-前瞻性COVIP研究的结果

2022-08-096
OAAI
The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years (vol 36, pg I646, 2022)
LEUKEMIA
IF13.4
2022-07-150
OA
Variations in end-of-life care practices in older critically ill patients with COVID-19 in Europe
2022-04-229
OA
The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years
LEUKEMIA
IF13.4
2022-04-128
PRE
Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19 (vol 48, pg 435, 2022)
2022-03-311
OAAI